Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Waked

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Viral Hepatitis|February 2, 2017
National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of careW El-Akel, M H El-Sayed, M El Kassas, et al.
Alimentary Pharmacology & Therapeutics|December 2, 2017
Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real-world results from 18 378 patients in EgyptH Omar, W El Akel, T Elbaz, et al.
Alimentary Pharmacology & Therapeutics|January 11, 2017
Sofosbuvir-based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in EgyptA Elsharkawy, R Fouad, W El Akel, et al.
Journal of Viral Hepatitis|April 10, 2014
Historical epidemiology of hepatitis C virus (HCV) in selected countriesP Bruggmann, T Berg, A L H Øvrehus, et al.
Journal of Viral Hepatitis|April 10, 2014
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigmH Razavi, I Waked, C Sarrazin, et al.
Journal of Viral Hepatitis|April 10, 2014
Strategies to manage hepatitis C virus (HCV) disease burdenH Wedemeyer, A S Duberg, M Buti, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Viral Hepatitis|February 2, 2017
National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of careW El-Akel, M H El-Sayed, M El Kassas, et al.
Alimentary Pharmacology & Therapeutics|December 2, 2017
Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real-world results from 18 378 patients in EgyptH Omar, W El Akel, T Elbaz, et al.
Alimentary Pharmacology & Therapeutics|January 11, 2017
Sofosbuvir-based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in EgyptA Elsharkawy, R Fouad, W El Akel, et al.
Journal of Viral Hepatitis|April 10, 2014
Historical epidemiology of hepatitis C virus (HCV) in selected countriesP Bruggmann, T Berg, A L H Øvrehus, et al.
Journal of Viral Hepatitis|April 10, 2014
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigmH Razavi, I Waked, C Sarrazin, et al.
Journal of Viral Hepatitis|April 10, 2014
Strategies to manage hepatitis C virus (HCV) disease burdenH Wedemeyer, A S Duberg, M Buti, et al.
Pageof 2